Augustine Therapeutics

📍 Leuven, Belgium🗓 Founded 2019👥 20 employees💰 Last funded Jan 2025
Biotechnology Research🌐 augustinetx.com
Website LinkedIn
Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.
6
Total investors
5
Early stage
0
Mid stage
1
Late stage
2019
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Belgium
5
Denmark
1
Investor activity2019–2025 · investors recorded per year
201942020120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Augustine Therapeutics?
Augustine Therapeutics has 6 investors on record on gritt.io, including 5 early-stage backers and 1 late-stage investors.
When did Augustine Therapeutics last raise funding?
The most recent investment in Augustine Therapeutics recorded on gritt.io was in January 2025.
When was Augustine Therapeutics founded?
Augustine Therapeutics was founded in 2019.
What industry is Augustine Therapeutics in?
Augustine Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Augustine Therapeutics based?
Augustine Therapeutics is headquartered in Leuven, Belgium.